BackCytoMed Therapeutics Overview

CytoMed Therapeutics Intangible Assets

Track CytoMed Therapeutics's intangible assets ($120K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$124539.00
83.29% YoYΔ $56591.00 vs prior year quarter

Peer average

Loading

CytoMed Therapeutics Intangible Assets History

Loading

CytoMed Therapeutics vs. peers: Intangible Assets Comparison

Loading

CytoMed Therapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CytoMed Therapeutics (GDTC) FAQ

As of the most recent data (December 2025), GDTC shows a intangible assets of $120K. That compares with $68K in the prior-year period — up 83.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GDTC's intangible assets is now $120K (was $68K) — a 83.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CytoMed Therapeutics is outperforming or lagging.

Tracking GDTC's intangible assets over time shows whether CytoMed Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $120K That compares with $68K in the prior-year period — up 83.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has CytoMed Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $120K) with ownership activity and broader fundamentals.